1. Introduction
Surface plasmons (SPs) are collections of electrons oscillating and propagating along the surface of a metal. Under certain conditions, a surface plasmon wave (SPW) is produced as the incident light interacts with free electrons near the metal/dielectric interface. When the incident wave vector satisfies the wave vector’s matching condition, the energy of the incident light is converted to that of the SPW in large quantities, resulting in a decrease in the energy of the reflected light, which is called surface plasmon resonance (SPR) [
1]. Therefore, SPR sensing systems can monitor the binding process of surface molecules by detecting alterations in the SPR position of the sample, and researchers can obtain important information, such as the binding and dissociation constants by analyzing the binding process profile [
2]. To achieve high-throughput detection, SPR has been combined with imaging technology to develop a high-throughput, high-sensitivity SPR imaging sensing system (SPRi) [
3,
4]. Conventional SPRi has low spatial resolution and cannot detect single molecules or nanoparticles; therefore, SPR microscopy (SPRM) was developed to address this challenge. Two typical SPRM systems have been developed, i.e., prism-based SPRM [
4] and objective-based SPRM [
5]. Prism-based SPRM has higher sensitivity and throughput. Our group has proposed wavelength-scanning surface plasmon resonance microscopy (WS-SPRM), which serves as a label-free biosensor capable of measuring cell-substrate interactions [
6]. We also combined the optothermophoretic flipping method with SPRM and actively drive the aggregation of protein molecules toward the sensing surface, which significantly improves the sensitivity [
7].
However, prism-based SPRM is limited by the working distance of the objective lens and imaging distortion, and it is difficult to distinguish the dynamic process of molecules or nanoparticles in the submicron region. Objective-based SPRM has the characteristics of high spatial resolution, which is more suitable for exploring the dynamic process of sparse particles [
8]. For example, Tao et al. built an oil-immersion objective SPRM based on a commercial microscope and studied cell-matrix interactions by detecting alterations in SPR intensity [
9]. Karan et al. further investigated antimicrobial susceptibility testing [
10]. Aaron et al. monitored the interaction of DNA molecules carrying nanoparticle balls in real time [
11]. Yang et al. report an optical method for imaging and size analysis of exosomes using interferometric plasma microscopy (iPM) [
12]. Yu et al. further analyzed individual DNA molecules quantitatively [
13] and achieved high-resolution imaging of nanoparticles using a semicircle-like filter utilized in the frequency domain and a deconvolution algorithm [
14].
In this study, total internal reflection-based surface plasmon resonance microscopy (TIR-SPRM) is developed. The TIR-SPRM system uses a wavelength-adjustable femtosecond laser as the light source. The femtosecond light source has excellent parallelism and a broader spectrum range so that the speckles induced by the light interference can be minimized. Therefore, we can obtain high quality SPR images, and a three-dimensional displacement stage is implemented to adjust the incident angle via the movement of the TL1 and diaphragm (
Figure 1). Therefore, the angle and wavelength can be optimized simultaneously, and thus the point of maximum absorption can be found without knowing the specific refractive index of the sample. The ability of the system to monitor biomolecular interactions at the microscopic scale is verified by detecting the specific binding of the human IgG and goat anti-human IgG antibodies. In addition, the imaging resolution of 248 nm without SPR-induced imaging distortion is achieved, in which the parabolic tailing in the nanoparticle image is removed by a designed ring filter and deconvolution algorithm at the Fourier domain.
3. Results and Discussion
To verify the ability of TIR-SPRM to monitor the interaction between molecules, a biomolecular interaction experiment was designed. First, the surface of the chip with the gold film was successively cleaned with deionized water and absolute ethanol and blown dry with nitrogen. After these operations, tiny molecules on the surface of the chip were removed, thereby preventing interference with the experimental results. Subsequently, the chip with the gold film was packaged to create a microfluidic channel, and the antigen was immobilized on the gold membrane surface by physical adsorption method, and the experimental steps were as follows.
First, phosphate-buffered saline (PBS, 0.01 M, PH = 7.4) was injected into the microfluidic channel, and its SPR signal intensity change was monitored in real time. When its SPR signal intensity was stable, 20 μg/mL of human IgG antigen was injected. When human IgG was stably bound to the sensing surface of the gold membrane and its SPR signal intensity became stable, the weakly attached human IgG antigen was washed away by injecting PBS. After the SPR signal intensity became stable, 10 mg/mL bovine serum albumin was injected to occupy the empty sites on the chip to prevent the antibodies from binding to the empty sites on the chip method. Similarly, when the SPR signal intensity stabilized, PBS was injected and the free BSA was washed away. After the above steps, goat anti-human IgG antibody of 15 ug/mL was passed to specifically bind to the modified human IgG antigen on the surface of the chip, and after its SPR signal intensity was smooth, PBS was injected to wash away the free goat anti-human IgG antibody. Specific SPR response curves are illustrated in
Figure 3A. The refractive index unit (RIU) of human IgG antigen changed by 2.20 × 10
−3 during fixation on the surface of the gold film. When BSA was injected, the RIU changed by 2.53 × 10
−3. The reason for the jump in the curve was that the concentration of BSA was much greater than that of the human IgG antigens. When the goat anti-human IgG antibody was injected, the RIU changed by 1.98 × 10
−3.
To verify the specificity in the human IgG antigen and the goat anti-human IgG antibody interaction experiment, we added a control experiment between 20 μg/mL of human IgG antigen and 15 μg/mL of the goat anti-rat IgG antibody, and the procedure of the control experiment is identical to the human IgG and the goat anti-human IgG antibody experiment. The results are shown in
Figure 3B, which shows that when 20 μg/mL human IgG was injected, the RIU changed by 2.20 × 10
−3. When 10 mg/mL of BSA was utilized to block redundant sites on the chip surface, the RIU changed by 2.86 × 10
−3. When 15 μg/mL of the goat anti-rat IgG antibody was introduced, the RIU did not change, which indicates that human IgG did not bind to the goat anti-rat IgG antibody, thus proving that the system has the ability to detect specific binding between biomolecules.
To verify the high-resolution imaging performance of TIR-SPRM, a solution with 200 nm polystyrene nanospheres was injected into the microfluidic chip. The solvent of in the 200 nm polystyrene nanosphere solution was PBS which is the buffer used for biomolecule binding experiment so that the overall solution refractive index is identical to the biosensing experiment. Furthermore, CMOS was utilized at a speed of 96 f/s for 10 s to obtain SPRM images of the SRRM background and 200 nm polystyrene nanospheres, respectively. The background noise of the system was further removed by time subtraction [
19], and the original SPRM image of the obtained polystyrene nanospheres is illustrated in
Figure 4A. A two-dimensional Fourier transform was then performed, as illustrated in
Figure 4A, and the result is illustrated in
Figure 4B, in which the spectrum of the two rings contains the coherent superposition spectrum of the 200 nm polystyrene nanospheres.
The PSF of the TIR-SPRM system was derived from a single 200 nm polystyrene nanosphere indicated by the arrow in
Figure 4A, and the result is shown in
Figure 5B. Subsequently, a two-dimensional Fourier transform was performed, and the results are illustrated in
Figure 5B. The intensity values of the dotted line on the left circle in
Figure 5B were extracted and plotted as curves, as illustrated in
Figure 5E,F. The black points represent the actual intensity value of the ring along the dotted line, and the red curve is the fitted Lorentzian function. By fitting the curve, the ring width
in the two directions in
Figure 5B was calculated as 0.48 μm
−1 and 0.42 μm
−1, respectively. The slight difference in the ring widths in these two directions was affected by the focal depth of the objective lens, and a larger
was chosen because more information could be obtained.
The other parameters of
were calculated by substituting the center wavelength of 720 nm, the refractive index of PBS solution of 1.338, and metal/dielectric constant into the formula (1), and the calculated results were:
,
=
and
. The center position of the circle and values of
and
were substituted into Equation (5) to construct
, and the result is illustrated in
Figure 5C. The spectrum of the object containing only the scattered field was then obtained by filtering
Figure 5B using
Figure 5C, and the result is illustrated in
Figure 5D.
The filter illustrated in
Figure 5C was applied to filter
Figure 4B to obtain the filtered spectrum. Furthermore, the filtered spectrum was deconvoluted, and the 200 nm polystyrene nanospheres image was reconstructed, as illustrated in
Figure 6B. The intensity curves for the polystyrene nanospheres in the L direction marked by arrows in the original SPRM image in
Figure 6A and the reconstructed image in
Figure 6B were obtained, as illustrated in
Figure 6C. In the L direction, the full widths at half maximum (FWHM) of the polystyrene nanospheres before and after reconstruction were 416 nm and 248 nm, respectively, demonstrating that the resolution of SPRM was increased by 1.68 fold.
In order to better demonstrate the SPR imaging and biosensing ability, we also conducted a transferrin biomolecular interaction experiment. First, 30 mg/mL of transferrin antibody 2 carrying 100 nm polystyrene particles (PS) and 20 μg/mL of transferrin antigen were mixed at a concentration of 1:100 and stirred for 30 min, hereinafter referred to as mixture-PS.
Then, phosphate-buffered saline (PBS, 0.01 M, PH = 7.4) was injected into the microfluidic channel, and its SPR signal intensity change was monitored in real time. When its SPR signal intensity was stable, 20 μg/mL of transferrin antibody 1 as ligand was injected. When transferrin antibody 1 was stably bound to the sensing surface of the gold membrane and its SPR signal intensity became stable, the weakly attached transferrin antibody 1 was washed away by injecting PBS. After the SPR signal intensity became stable, 10 mg/mL bovine serum albumin was injected to occupy the empty sites on the chip to prevent the anti-bodies from binding to the empty sites on the chip method. Similarly, when the SPR signal intensity stabilized, PBS was injected and the free BSA was washed away. Subsequently, the mixture-PS was injected as the analyte to specifically bind to the modified transferrin antibody 1 on the surface of the chip, and after its SPR signal intensity was stable, PBS was injected to wash away the unbonded analyte.
The specific binding curve of analyte and ligand is shown in
Figure 7A; when 15 μg/mL of mixture-PS (analyte) was introduced as specific binding, the change in RIU was 8.57 × 10
−4.
Figure 7C was an image collected by the system when the mixture-PS specifically binds to the ligand, and the image was filtered and deconvoluted to obtain the result of
Figure 7D. To illustrate the signal amplification effect of nanoparticle spheres, we added a set of control experiments, and the control experimental ligand was still 20 μg/mL transferrin antibody 1. Additionally, 30 mg/mL transferrin antibody 2 without 100 nm polystyrene particles was mixed with 20 ug/mL of transferrin antigen at a concentration of 1:100 and left for 30 min, hereinafter referred to as mixture-noPS. The specific binding curve of analyte to mixture-noPS is shown in
Figure 7B; when 15 μg/mL of mixture mixture-noPS was introduced as specific binding, the change in RIU was 1.06 × 10
−4. By comparing
Figure 7A with
Figure 7B, the nanoparticles amplify the protein signal by 8 times, which proves that the nanoparticles have a signal amplification effect on protein-specific experiments.